Caseous Lymphadenitis (CL)

Caseous lymphadenitis represents one of the most economically significant and frustrating chronic bacterial diseases affecting goats and sheep worldwide, characterized by abscess formation in lymph nodes and internal organs. This condition, caused by the bacterium Corynebacterium pseudotuberculosis, earns its common name from the distinctive cheesy or caseous appearance of purulent material within affected lymph nodes. The disease causes chronic debilitation in severely affected animals while creating persistent environmental contamination that perpetuates infection within herds. Understanding CL is essential for goat and sheep producers seeking to protect their animals and prevent the substantial losses this disease causes.

Caseous lymphadenitis affects both goats and sheep, though disease manifestations and severity patterns may differ somewhat between species. The condition occurs globally wherever small ruminants are raised, with prevalence varying from minimal in herds with rigorous prevention programs to endemic status affecting large proportions of animals in herds without control measures. Both external and internal forms of the disease occur, with external abscesses affecting peripheral lymph nodes being more readily recognized while internal abscesses in thoracic and abdominal lymph nodes and organs cause insidious losses that may go undetected until slaughter or necropsy.

The economic and welfare impact of CL extends throughout affected herds in multiple ways. Clinically affected animals with external abscesses face pain, discomfort, and cosmetic problems that reduce show and sale values. Internal disease causes chronic weight loss, reduced production, and premature death that may be attributed to other causes without definitive diagnosis. Carcass condemnation at slaughter due to internal abscesses represents direct economic losses for meat producers. Environmental contamination from ruptured abscesses spreads infection to previously healthy animals, perpetuating endemic cycling within herds. The chronic nature of infection and difficulty achieving complete cure make CL particularly challenging to eliminate once established.

Managing CL requires integrated approaches combining rigorous biosecurity, vaccination where available, strategic culling, and careful management of infected animals to prevent environmental contamination. While individual abscesses can be treated through surgical drainage and local therapy, eliminating the organism from chronically infected animals proves extremely difficult. Prevention through maintaining closed herds, testing incoming animals, and implementing vaccination programs offers the most effective approach to protecting goat populations from this persistent disease. Producers committed to CL control can substantially reduce disease impact through consistent application of prevention and management protocols.

The primary cause of caseous lymphadenitis is infection with Corynebacterium pseudotuberculosis, a gram-positive bacterium with exceptional ability to survive in the environment and evade host immune defenses. This organism produces a phospholipase D exotoxin that damages blood vessel walls and enables bacterial spread from initial infection sites to lymph nodes and internal organs. The waxy lipid-rich cell wall of C. pseudotuberculosis protects it from immune system attack and enables prolonged survival within host macrophages, contributing to chronic infection patterns. Two biotypes of the organism exist, with the biovar ovis strain primarily affecting sheep and goats while biovar equi affects horses and cattle.

Genetic predisposition to CL susceptibility appears to exist within small ruminant populations, though environmental and management factors typically predominate in determining infection patterns. Research has identified genetic variation in immune responses to C. pseudotuberculosis that influences disease severity following infection. Some breed differences in CL prevalence have been observed, though these often reflect management intensity differences rather than inherent susceptibility variation. Individual variation in immune competence affects ability to contain infection and prevent progressive internal spread.

Environmental contamination represents the primary reservoir maintaining CL infection within endemic herds. When external abscesses rupture, they release massive numbers of bacteria into the environment where organisms can survive for months in soil, on equipment, and in organic matter. Shearing wounds, skin abrasions, and mucous membrane exposure provide entry points for environmental bacteria to initiate new infections. Contaminated housing facilities, handling equipment, and shared feeding areas serve as ongoing infection sources. The organism's exceptional environmental stability makes premises decontamination extremely challenging once infected animals have been present.

Risk factors for CL acquisition include exposure to infected animals or contaminated environments, skin injuries providing bacterial entry points, and management practices facilitating transmission. Young animals raised in endemic herds face high infection risk from exposure to adults shedding bacteria from draining abscesses. Shearing creates widespread skin wounds that provide optimal entry for environmental bacteria, with shared equipment spreading infection between animals. Overcrowded conditions increase both direct contact transmission and environmental contamination levels. Stress from transport, nutritional deficiency, or concurrent illness may increase susceptibility to infection following exposure.

The pathophysiology of CL infection begins when bacteria enter through skin wounds or mucous membranes and are taken up by macrophages that transport organisms to regional lymph nodes. Rather than being destroyed by these immune cells, C. pseudotuberculosis survives and multiplies within macrophages, protected by its lipid-rich cell wall. Bacterial replication triggers intense inflammatory responses that lead to lymph node enlargement and abscess formation with characteristic laminated purulent material. The phospholipase D toxin damages blood vessels, promoting bacterial spread to distant lymph nodes and internal organs. Progressive internal abscessation affects lungs, liver, kidneys, and abdominal lymph nodes, causing chronic debilitation and eventual organ failure in severe cases.

Early warning signs of caseous lymphadenitis often go unrecognized until abscess development becomes obvious upon physical examination or observation. Initial infection produces minimal clinical signs as bacteria travel to lymph nodes and begin the slow process of abscess formation. Subtle enlargement of superficial lymph nodes may be detectable through careful palpation before abscesses become visually apparent. Animals in early disease stages may show vague signs of ill-thrift including slightly reduced appetite, modest weight loss, or decreased energy compared to herdmates. Fever may occur transiently during initial infection and bacterial spread phases.

Common symptoms of established external CL include visible and palpable swelling of peripheral lymph nodes that progresses to obvious abscess formation. The submandibular lymph nodes beneath the jaw, prescapular nodes in front of the shoulder, prefemoral nodes in the flank region, and supramammary nodes above the udder are most commonly affected. Abscesses initially feel firm as caseous material accumulates within the lymph node capsule. Mature abscesses may soften as material liquefies centrally, eventually rupturing through the skin to discharge thick, greenish-white to yellow purulent material with characteristic cheesy consistency. Multiple abscesses affecting different lymph node regions may develop as disease progresses.

Behavioral changes in goats with CL reflect general discomfort and potential internal organ involvement. Animals with large external abscesses may show guarding behavior or reluctance to turn the head if submandibular nodes are affected. Reduced feed intake develops in animals with extensive internal disease causing chronic malaise. Separation from the herd and decreased activity indicate advancing illness. Animals with respiratory involvement from lung abscesses may show exercise intolerance before obvious respiratory distress develops. Chronic weight loss despite apparently adequate nutrition suggests internal disease progression.

Physical examination findings in CL-affected animals include palpable lymph node enlargement ranging from subtle swelling to dramatic abscess formation. External abscesses may feel fluctuant when material has liquefied or firm when caseous content remains inspissated. Overlying skin may appear normal, reddened, or show evidence of imminent rupture with thinning and hair loss. Auscultation of thorax in animals with internal involvement may reveal abnormal lung sounds from abscessation. Abdominal palpation or rectal examination might detect enlarged internal lymph nodes in advanced cases. Body condition scoring reveals progressive weight loss despite adequate feeding in animals with significant internal disease burden.

Symptom progression in CL follows patterns of chronic bacterial infection with episodic abscess development and rupture. External abscesses typically require weeks to months to develop from initial infection to mature drainage-ready lesions. Following spontaneous or surgical drainage, abscesses may heal externally while organisms persist internally, leading to recurrence or development of additional lesions. Internal disease progresses insidiously, with animals appearing relatively normal until organ function becomes compromised by extensive abscessation. Terminal stages involve severe weight loss, weakness, and organ failure from massive internal involvement.

Emergency symptoms requiring immediate attention include abscesses in locations causing mechanical problems such as large submandibular abscesses interfering with breathing or swallowing. Sudden deterioration suggesting internal abscess rupture with potential septicemia warrants urgent veterinary evaluation. Severe weight loss and weakness indicating advanced internal disease requires welfare assessment and potential euthanasia consideration. Any CL-affected animal showing signs of systemic illness beyond localized abscess development should receive prompt veterinary attention to determine prognosis and appropriate management.

Clinical examination provides presumptive diagnosis of CL based on characteristic abscess presentation in typical lymph node locations. Veterinarians assess the number, distribution, and maturity of abscesses during physical examination. Palpation of all peripheral lymph node regions identifies additional lesions beyond those visually apparent. Assessment of body condition and general health status helps evaluate potential internal involvement. Clinical diagnosis based on external abscess characteristics proves reliable in endemic areas where CL is common, though laboratory confirmation is valuable for definitive diagnosis.

Diagnostic testing confirms CL diagnosis and provides information valuable for herd management decisions. Bacterial culture from abscess material definitively identifies C. pseudotuberculosis and may provide antimicrobial sensitivity information. Serological testing detects antibodies against the organism, indicating exposure though not necessarily active clinical disease. The synergistic hemolysis inhibition test and ELISA methods are commonly used for antibody detection. PCR testing can identify the organism's genetic material directly. Cytological examination of aspirated material showing characteristic caseous content supports clinical diagnosis while awaiting culture results.

Differential diagnosis requires consideration of other conditions causing lymph node enlargement or abscess formation in small ruminants. Abscesses from other bacterial causes including Arcanobacterium pyogenes and various streptococcal and staphylococcal species may appear similar to CL. Injection site reactions and traumatic lesions occasionally resemble developing CL abscesses. Lymph node enlargement from other infectious causes including CAE-associated lymphoid hyperplasia requires differentiation. Neoplastic conditions affecting lymph nodes occur rarely in goats but should be considered when presentation is atypical. Culture and identification of the causative organism provides definitive differentiation.

Herd-level diagnostic approaches establish infection prevalence and guide control program implementation. Serological surveys testing all animals identify the proportion of infected individuals including those with internal disease not apparent on physical examination. Regular physical examination of all animals detects external abscesses for isolation and treatment. Necropsy examination of culled animals and mortalities reveals internal lesion prevalence and distribution. Slaughter surveillance reporting carcass condemnation rates provides additional information on internal disease occurrence. Comprehensive diagnostic data informs strategic decisions about culling, vaccination, and management modifications.

Emergency treatment of acute CL complications focuses on addressing immediate welfare concerns rather than eliminating underlying infection. Animals with abscesses causing mechanical obstruction of breathing or swallowing require urgent drainage to relieve pressure. Systemic illness suggesting abscess rupture and septicemia necessitates supportive care and antimicrobial therapy. Providing comfortable housing and easy access to feed and water supports animals during acute disease episodes. Emergency assessment should include welfare evaluation and consideration of humane euthanasia when prognosis is poor.

Medical management of CL abscesses typically involves surgical drainage combined with local and potentially systemic therapy. Mature abscesses identified by fluctuation and impending rupture are lanced under aseptic conditions, with purulent material collected and disposed to prevent environmental contamination. Abscess cavities are flushed with antiseptic solutions and may be packed or treated with intralesional antimicrobials. Systemic antibiotic therapy has limited efficacy against C. pseudotuberculosis due to the organism's intracellular location and walled-off nature of established abscesses. Antimicrobial treatment is most likely to benefit animals with early infection before mature abscesses develop, though even prolonged therapy rarely achieves complete cure.

Surgical approaches to CL focus on abscess drainage and minimizing environmental contamination from purulent discharge. Careful site preparation and aseptic technique reduce secondary infection risk. Complete abscess excision rather than simple drainage may improve cure rates by removing the entire lesion including the capsule, though this approach is more invasive and technically demanding. All contaminated materials including purulent discharge, bedding, and equipment must be carefully contained and disposed to prevent spread. Post-surgical wound management promotes healing while minimizing contamination of the environment.

Supportive care measures address overall health maintenance in CL-affected animals retained in the herd. Nutritional support with high-quality feed helps maintain body condition in animals with chronic disease. Parasite control and attention to other health needs prevent compounding problems. Isolation of animals with draining abscesses protects herdmates from exposure. Stress reduction through appropriate housing and handling supports immune function. Regular monitoring identifies disease progression warranting management adjustments.

Herd treatment protocols for endemic CL situations combine individual animal treatment with population-level prevention measures. Vaccination programs where effective vaccines are available reduce new infection incidence and disease severity. Systematic identification and isolation of infected animals limits environmental contamination. Enhanced biosecurity and hygiene practices reduce transmission opportunities. Strategic culling of severely affected animals removes major contamination sources. These combined approaches gradually reduce prevalence in endemic herds over time.

Treatment decision factors for CL-affected animals balance individual animal welfare, economic considerations, and herd health implications. Animals with single external abscesses may be treated and retained if valuable for breeding or production, with appropriate isolation to prevent transmission. Severe or progressive internal disease warrants humane euthanasia when quality of life is compromised. Herd elimination goals may favor culling infected animals regardless of clinical status to accelerate prevalence reduction. Veterinary guidance helps navigate these decisions appropriately for specific situations.

Recovery expectations for CL must account for the chronic nature of infection and limited ability to achieve complete bacterial elimination. External abscesses heal following drainage, but organisms typically persist within the animal, leading to potential recurrence or development of additional lesions over time. Animals recovering from visible external disease may harbor internal abscesses that continue progressing without obvious clinical signs. True microbiological cure following treatment is rare, meaning recovery represents clinical improvement rather than disease elimination.

Post-treatment management following abscess drainage focuses on wound healing and preventing environmental contamination. Surgical sites require monitoring for adequate drainage and healing progress. Protective covering of healing wounds prevents fly strike and secondary infection. Isolation from uninfected herdmates should continue until wound healing is complete and no drainage persists. Repeated examination identifies recurrent abscess development indicating persistent infection. Gradual reintegration with the herd may occur following complete healing, though permanent separation or culling of positive animals is often preferable for disease control.

Prognosis factors influencing outcomes include extent of internal versus external disease, number of affected sites, and overall health status. Animals with single external abscesses carry better prognosis for maintained production than those with multiple lesions or internal involvement. Young animals recently infected may have better outcomes than chronically infected adults with established internal disease. Body condition at diagnosis predicts tolerance of chronic disease; thin animals with extensive involvement have poor prognosis. Individual immune competence affects ability to contain infection and limit progression.

Return to production considerations must account for ongoing infection risk and transmission potential. Infected animals pose transmission risk to herdmates through abscess drainage and environmental contamination regardless of clinical appearance. Milk from infected dairy goats should not be used for human consumption or feeding to uninfected kids. Breeding infected animals perpetuates the cycle of disease within the herd. Selling or transferring infected animals to other herds spreads disease to new populations. Producers should develop strategies for permanent removal of infected animals from breeding and production roles while managing welfare during any holding period.

Vaccination against CL offers an important prevention tool in regions where effective vaccines are available. Commercial CL vaccines exist in several countries and have demonstrated ability to reduce disease incidence and severity, though they do not provide complete protection. Vaccine protocols typically require initial immunization with boosters to establish immunity, followed by annual revaccination. Vaccination should be implemented as part of comprehensive prevention programs rather than relied upon as the sole control measure. Autogenous vaccines prepared from herd-specific isolates may be considered where commercial products are unavailable or ineffective.

Biosecurity measures preventing CL introduction represent the foundation of maintaining disease-free status in uninfected herds. Maintaining closed herds that never introduce outside animals eliminates the primary route of CL introduction. When purchases are necessary, sourcing only from herds with documented CL-free status and negative testing history reduces risk. Quarantine of new arrivals with physical examination and serological testing before herd integration identifies infected animals before exposure occurs. Avoiding shared equipment, facilities, and transportation with potentially infected animals prevents indirect transmission.

Environmental management and contamination prevention limit transmission within endemic herds. Prompt isolation of animals developing abscesses prevents environmental contamination from drainage. Careful containment and disposal of purulent material from drained abscesses removes infectious material from the premises. Thorough cleaning and disinfection of housing, equipment, and handling facilities reduces bacterial survival. Avoiding practices that create skin wounds, such as dehorning with shared equipment or rough handling, reduces infection opportunities.

Management practices supporting CL prevention address transmission risk factors throughout production systems. Minimizing skin injuries through careful handling and appropriate facility design reduces bacterial entry points. Disinfecting shearing and hoof trimming equipment between animals prevents transmission during routine procedures. Avoiding overcrowding reduces both injury risk and direct contact transmission opportunities. Providing good nutrition and minimizing stress supports immune function and disease resistance. Regular physical examination of all animals identifies infections early for prompt isolation and management.

Testing and culling protocols enable systematic CL elimination from infected herds over time. Serological testing of all animals identifies infected individuals including those with internal disease not detected on physical examination. Regular physical examination detects new external abscess development between serological testing events. Strategic culling of seropositive and clinically affected animals removes infection sources from the herd. Replacement with negative-tested animals from CL-free sources gradually shifts herd status. These programs require several years of consistent implementation but can successfully eliminate CL from infected populations.

Daily management and monitoring for CL requires consistent attention to animal observation and biosecurity practices. Regular physical examination of all animals identifies developing abscesses for prompt isolation and management. Monitoring body condition tracks chronic disease effects and identifies animals requiring intervention. Observing behavior and activity levels detects general illness that might indicate internal disease progression. Maintaining strict separation between CL-positive and CL-negative groups prevents ongoing transmission within the herd.

Housing and environmental management for CL-infected herds addresses containment and decontamination challenges. Designated isolation housing for animals with draining abscesses prevents environmental contamination of main herd areas. Deep cleaning and disinfection of isolation facilities between occupants reduces bacterial accumulation. Careful management of bedding, feed, and water sources prevents cross-contamination between animal groups. Consideration of airflow patterns and drainage prevents inadvertent spread of contamination through facilities.

Herd health programs addressing CL integrate testing, vaccination, and management into comprehensive control strategies. Establishing regular testing schedules for serological surveillance identifies new infections and monitors program progress. Implementing vaccination protocols where appropriate reduces disease incidence and severity. Developing and following consistent protocols for managing infected animals ensures appropriate biosecurity regardless of which personnel are present. Regular veterinary consultation provides expertise for program design and complex case management.

Record keeping and monitoring systems support effective CL management through accurate documentation. Maintaining individual animal testing histories and clinical records tracks infection status and disease progression. Recording all abscess occurrences with location, treatment, and outcomes documents disease patterns. Monitoring herd-level prevalence over time demonstrates control program effectiveness. Documenting biosecurity measures and compliance supports continuous improvement efforts. Analysis of accumulated data guides management decisions and resource allocation.

Economic considerations in CL management influence program intensity and strategic decisions. Calculating losses from clinical disease, carcass condemnation, reduced sale values, and premature culling documents disease costs. Evaluating prevention investments including vaccination, testing, and facility modifications guides resource allocation. Comparing costs of maintaining infected animals versus accelerated culling informs individual management decisions. Assessing market value differences between CL-free and untested animals demonstrates economic returns from prevention programs. Long-term economic modeling helps producers commit to multi-year elimination programs despite upfront investment requirements.

High-risk breeds for caseous lymphadenitis include those raised in management systems with high disease prevalence rather than breeds with inherent susceptibility differences. Dairy goat breeds including Alpine, LaMancha, Nubian, Oberhasli, Saanen, and Toggenburg commonly experience CL when raised in endemic conditions, reflecting intensive management facilitating transmission rather than breed-specific vulnerability. Meat goat breeds such as Boer and Kiko encounter CL in endemic regions, with production losses compounding economic impact. Fiber goats including Angora breeds face CL challenges in some production areas. Essentially all goat breeds and sheep breeds are susceptible when exposed to the organism.

Production type considerations influence CL risk patterns and management approaches. Dairy goat operations with intensive management, frequent handling, and shared equipment face high transmission risk when disease is introduced. Meat goat operations may experience lower transmission rates with more extensive management but face significant carcass condemnation losses when internal disease is present. Show and exhibition animals face exposure risk at events where animals from multiple herds commingle. Fiber goat operations performing regular shearing create transmission opportunities through shared equipment and skin wounds. Production goals should guide CL management intensity and elimination timeline decisions.

Genetic selection against CL susceptibility represents an emerging area of research interest. Studies have identified variation in immune responses to C. pseudotuberculosis suggesting potential for selection toward relative resistance. Currently, genetic approaches focus on avoiding amplification of susceptible genetics by not breeding infected animals and sourcing replacements from CL-free herds. Selection for overall immune competence and disease resistance may provide indirect protection against CL along with other infectious challenges. Future development of genetic markers for CL resistance could enable more targeted selection strategies.

Commonly co-occurring conditions with CL include other health challenges that may be exacerbated by chronic infection or share management risk factors. Parasite burdens often increase in animals debilitated by CL, creating combined effects on body condition and productivity. Nutritional deficiencies may compound chronic disease effects on weight maintenance. Other infectious diseases circulating in intensively managed herds may affect CL-infected animals more severely due to compromised immune function. Foot rot and other external infections may share transmission risk factors with CL in terms of skin injury and environmental contamination.

Conditions with similar clinical symptoms requiring differentiation from CL include other causes of abscess formation and lymph node enlargement. Abscesses caused by Arcanobacterium pyogenes and other pyogenic bacteria present similarly to CL and require culture for differentiation. Injection site reactions following vaccination or medication may initially resemble developing CL abscesses. Traumatic swellings and hematomas occasionally mimic lymph node enlargement. Melioidosis caused by Burkholderia pseudomallei occurs in some geographic regions and can produce similar abscess presentations. Tuberculosis, though rare in goats, can cause granulomatous lymph node enlargement requiring differentiation. Definitive diagnosis through culture or molecular testing establishes the specific cause.

Complications and sequelae of CL extend disease impact beyond localized abscess formation. Chronic weight loss from internal organ involvement leads to debilitation and reduced productive capacity. Respiratory compromise from lung abscessation causes progressive exercise intolerance and dyspnea. Abscess rupture into body cavities causes peritonitis or pleuritis with potential fatal consequences. Secondary bacterial infection of draining abscess sites may occur. Chronic pain from large or multiple abscesses compromises welfare. These complications often determine when euthanasia becomes appropriate to prevent continued suffering in severely affected animals.